Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PBE vs IBBQ overlap: 55% of top holdings shared

Bottom line

How much do PBE and IBBQ overlap?

55% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 66.8% of PBE's assets and 61.8% of IBBQ's. They share a meaningful core but differ in the rest of the portfolio.

IBBQ holds far more positions (261 vs 33), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PBEIBBQ
Weight overlap (top 25)55%
Shared holdings14
Weight in shared holdings66.8%61.8%
Total positions33261
Expense ratio0.59%0.19%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings PBE and IBBQ have in common

Holding% of PBE% of IBBQOverlap
Invesco Private Prime Fund12.89%14.20%12.89%
Regeneron Pharmaceuticals, Inc.5.47%5.08%5.08%
Amgen Inc.5.22%7.10%5.22%
Vertex Pharmaceuticals Inc.4.99%7.38%4.99%
Invesco Private Government Fund4.97%5.48%4.97%
Royalty Pharma PLC4.94%1.90%1.90%
Biogen Inc.4.79%2.29%2.29%
Gilead Sciences, Inc.4.43%7.39%4.43%
United Therapeutics Corp.4.08%1.94%1.94%
Illumina, Inc.3.51%1.98%1.98%
Alnylam Pharmaceuticals, Inc.3.17%3.19%3.17%
Incyte Corp.3.06%1.53%1.53%
Neurocrine Biosciences, Inc.2.66%1.26%1.26%
Exelixis, Inc.2.64%1.04%1.04%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PBE

  1. CareDx, Inc. — 5.04%
  2. Bio-Techne Corp. — 3.73%
  3. Protagonist Therapeutics, Inc. — 3.40%
  4. Vericel Corp. — 3.27%
  5. Repligen Corp. — 3.04%
  6. Acadia Pharmaceuticals Inc. — 3.02%
  7. Halozyme Therapeutics, Inc. — 2.98%
  8. Qiagen N.V. — 2.89%
  9. BioMarin Pharmaceutical Inc. — 2.82%
  10. BioCryst Pharmaceuticals, Inc. — 2.63%
  11. Veracyte, Inc. — 2.60%

Only in IBBQ

  1. Revolution Medicines, Inc. — 2.48%
  2. argenx SE — 1.89%
  3. Insmed Inc. — 1.83%
  4. Roivant Sciences Ltd. — 1.71%
  5. Viatris Inc. — 1.49%
  6. Moderna, Inc. — 1.48%
  7. Guardant Health, Inc. — 1.35%
  8. Jazz Pharmaceuticals PLC — 1.16%
  9. Ascendis Pharma A/S — 1.10%
  10. Summit Therapeutics Inc. — 1.08%
  11. BridgeBio Pharma, Inc. — 1.02%

Asset mix

Asset typePBEIBBQ
Stocks100.1%99.9%
Cash & short-term funds17.9%19.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryPBEIBBQ
US108.6%103.8%
GB4.9%2.7%
NL2.9%2.5%
IE—1.9%
BM—1.7%
KY1.6%0.6%
FR—1.5%
DK—1.2%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PBE and IBBQ overlap?
About 55% by weight. 14 securities appear in both funds' top 25 holdings; they make up 66.8% of PBE's assets and 61.8% of IBBQ's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PBE and IBBQ have in common?
The largest shared holdings are Invesco Private Prime Fund, Amgen Inc., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals Inc., Invesco Private Government Fund.
Should I own both PBE and IBBQ?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PBE or IBBQ?
IBBQ is broader, with 261 positions versus 33 for PBE. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.